Syngene International Limited

Informe acción NSEI:SYNGENE

Capitalización de mercado: ₹274.1b

Syngene International Dirección

Dirección controles de criterios 3/4

El CEO de Syngene International's es Jonathan Hunt , nombrado en Jan 2016, tiene una permanencia de 8.25 años. compensación anual total es ₹84.75M, compuesta por 100% salario y 0% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.088% de las acciones de la empresa, por valor de ₹243.47M. La antigüedad media del equipo directivo y de la junta directiva es de 7.2 años y 6.8 años, respectivamente.

Información clave

Jonathan Hunt

Chief Executive Officer (CEO)

₹84.8m

Compensación total

Porcentaje del salario del CEO100.0%
Permanencia del CEO8.3yrs
Participación del CEO0.09%
Permanencia media de la dirección7.3yrs
Promedio de permanencia en la Junta Directiva6.8yrs

Actualizaciones recientes de la dirección

Recent updates

These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely

Mar 28
These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely

Do Syngene International's (NSE:SYNGENE) Earnings Warrant Your Attention?

Feb 14
Do Syngene International's (NSE:SYNGENE) Earnings Warrant Your Attention?

Earnings Not Telling The Story For Syngene International Limited (NSE:SYNGENE)

Jan 19
Earnings Not Telling The Story For Syngene International Limited (NSE:SYNGENE)

Is Syngene International (NSE:SYNGENE) A Risky Investment?

Nov 19
Is Syngene International (NSE:SYNGENE) A Risky Investment?

Is Now The Time To Put Syngene International (NSE:SYNGENE) On Your Watchlist?

Nov 01
Is Now The Time To Put Syngene International (NSE:SYNGENE) On Your Watchlist?

Syngene International (NSE:SYNGENE) Seems To Use Debt Rather Sparingly

Aug 07
Syngene International (NSE:SYNGENE) Seems To Use Debt Rather Sparingly

These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely

Apr 28
These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely

Here's Why We Think Syngene International (NSE:SYNGENE) Is Well Worth Watching

Apr 06
Here's Why We Think Syngene International (NSE:SYNGENE) Is Well Worth Watching

Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?

Jan 04
Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?

Syngene International (NSE:SYNGENE) Has A Pretty Healthy Balance Sheet

Dec 08
Syngene International (NSE:SYNGENE) Has A Pretty Healthy Balance Sheet

Is Syngene International (NSE:SYNGENE) Using Too Much Debt?

Aug 28
Is Syngene International (NSE:SYNGENE) Using Too Much Debt?

Syngene International Limited (NSE:SYNGENE) Shares Could Be 22% Above Their Intrinsic Value Estimate

Aug 10
Syngene International Limited (NSE:SYNGENE) Shares Could Be 22% Above Their Intrinsic Value Estimate

These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Reasonably Well

May 10
These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Reasonably Well

Does Syngene International (NSE:SYNGENE) Have A Healthy Balance Sheet?

Feb 02
Does Syngene International (NSE:SYNGENE) Have A Healthy Balance Sheet?

Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?

Nov 26
Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?

Here's Why Syngene International (NSE:SYNGENE) Can Manage Its Debt Responsibly

Sep 21
Here's Why Syngene International (NSE:SYNGENE) Can Manage Its Debt Responsibly

Here's Why I Think Syngene International (NSE:SYNGENE) Is An Interesting Stock

Aug 06
Here's Why I Think Syngene International (NSE:SYNGENE) Is An Interesting Stock

The CEO Of Syngene International Limited (NSE:SYNGENE) Might See A Pay Rise On The Horizon

Jul 14
The CEO Of Syngene International Limited (NSE:SYNGENE) Might See A Pay Rise On The Horizon

Is Syngene International (NSE:SYNGENE) A Risky Investment?

Jun 09
Is Syngene International (NSE:SYNGENE) A Risky Investment?

We Think Syngene International (NSE:SYNGENE) Can Stay On Top Of Its Debt

Feb 18
We Think Syngene International (NSE:SYNGENE) Can Stay On Top Of Its Debt

Syngene International Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Jan 23
Syngene International Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Jonathan Hunt en comparación con los beneficios de Syngene International?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2024n/an/a

₹5b

Dec 31 2023n/an/a

₹5b

Sep 30 2023n/an/a

₹5b

Jun 30 2023n/an/a

₹5b

Mar 31 2023₹85m₹85m

₹5b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹4b

Jun 30 2022n/an/a

₹4b

Mar 31 2022₹76m₹76m

₹4b

Dec 31 2021n/an/a

₹4b

Sep 30 2021n/an/a

₹4b

Jun 30 2021n/an/a

₹4b

Mar 31 2021₹65m₹65m

₹4b

Dec 31 2020n/an/a

₹4b

Sep 30 2020n/an/a

₹4b

Jun 30 2020n/an/a

₹4b

Mar 31 2020₹66m₹66m

₹4b

Dec 31 2019n/an/a

₹4b

Sep 30 2019n/an/a

₹4b

Jun 30 2019n/an/a

₹3b

Mar 31 2019₹90m₹47m

₹3b

Dec 31 2018n/an/a

₹3b

Sep 30 2018n/an/a

₹3b

Jun 30 2018n/an/a

₹3b

Mar 31 2018₹94m₹47m

₹3b

Compensación vs. Mercado: La compensación total de Jonathan($USD1.02M) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD539.67K).

Compensación vs. Ingresos: La compensación de Jonathan ha sido consistente con los resultados de la empresa en el último año.


CEO

Jonathan Hunt (54 yo)

8.3yrs

Permanencia

₹84,750,000

Compensación

Mr. Jonathan Brittan Hunt serves as the Managing Director of Syngene International Limited since April 1, 2020. He has been the Chief Executive Officer of Syngene International Ltd. since January 2016 and...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Jonathan Hunt
MD, CEO & Executive Director8.3yrs₹84.75m0.087%
₹ 239.7m
Sibaji Biswas
CFO & Executive Director4.4yrs₹34.14m0.017%
₹ 46.9m
Krishnan G
Head of Investor Relationsno datasin datos0.0013%
₹ 3.6m
Priyadarshini Mahapatra
Company Secretary & Compliance Officer4.8yrs₹4.72m0.0031%
₹ 8.6m
Sandeep Nair
Head of Corporate Communicationsno datasin datossin datos
Andrew Webster
Chief Human Resources Officer1.4yrssin datossin datos
Dhananjay Patankar
Head of Pharmaceutical & Biopharmaceutical Developmentno data₹10.80msin datos
Purushottam Singnurkar
Head of Formulations Developmentno data₹5.50m0.029%
₹ 80.1m
Ajit Manocha
Head of IT8.3yrssin datos0.00038%
₹ 1.0m
Jayashree Aiyar
Head of Discovery Biology8.3yrssin datos0.0060%
₹ 16.5m
Chetan Tamhankar
Head of Clinical Development & Stability Studies8.3yrssin datos0.0048%
₹ 13.2m
Rajendra Patil
Head of EHSS6.3yrssin datos0.0063%
₹ 17.4m

7.3yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de SYNGENE es experimentado (7.2 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Jonathan Hunt
MD, CEO & Executive Director7yrs₹84.75m0.087%
₹ 239.7m
Sibaji Biswas
CFO & Executive Directorless than a year₹34.14m0.017%
₹ 46.9m
Catherine Rosenberg
Non-Executive Director23.8yrs₹7.25m0.0022%
₹ 6.1m
Kiran Mazumdar-Shaw
Non-Executive Chairpersonno data₹8.23m0.0055%
₹ 15.1m
Vinita Bali
Lead Independent Director6.8yrs₹7.57msin datos
Vijay Kuchroo
Independent Director7.2yrs₹6.93m0.013%
₹ 34.5m
Nilanjan Roy
Additional Independent Directorless than a yearsin datossin datos
Kush Parmar
Independent Non Executive Director2.9yrs₹5.61msin datos
Paul Blackburn
Non-Executive Independent Director9.8yrs₹7.91m0.013%
₹ 34.5m
Sharmila Karve
Additional Independent Director4.8yrs₹7.57msin datos

6.8yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: La junta directiva de SYNGENE se considera experimentada (6.8 años de antigüedad promedio).